Evidence map›Paper›PMID 27374105›Full record

ArticleOncotarget2016

The essential role of GATA transcription factors in adult murine prostate.

Lijuan Xiao, Qin Feng, Zheng Zhang, Fen Wang, John P Lydon, Michael M Ittmann, Li Xin, Nicholas Mitsiades, Bin He

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Trial
  2. Article
  3. Cellular cartography reveals mouse prostate organization and determinants of castration resistance.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. FOXA1 in prostate cancer.Asian journal of andrology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Lijuan XiaoDepartment of Medicine, Section of Hematology and Oncology, Baylor College of Medicine, Houston, TX, USA.
Qin FengDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
Zheng ZhangDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
Fen WangThe Center for Cancer and Stem Cell Biology, Institute of Bioscience and Technology, Texas A&M Health Science Center, Houston, TX, USA.
John P LydonDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
Michael M IttmannDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.
Li XinDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
Nicholas MitsiadesDepartment of Medicine, Section of Hematology and Oncology, Baylor College of Medicine, Houston, TX, USA.
Bin HeDepartment of Medicine, Section of Hematology and Oncology, Baylor College of Medicine, Houston, TX, USA.
Baylor College of Medicine · USTexas A&M Health Science Center · USUnited States Department of Veterans Affairs · US

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI DAVID R ROWLEY · 2007 to 2026
$73.9M
Molecular Analysis of Uterine ReceptivityR01HD042311 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI LYDON, JOHN P · 2009 to 2023
$4.8M
An epigenomic approach to reactivate latent HIVR33AI122418 · NIAID · UNIVERSITY OF HOUSTON · PI FENG, QIN · 2018 to 2020
$1.4M
An epigenomic approach to reactivate latent HIVR21AI122418 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI FENG, QIN · 2016 to 2017
$436k
Androgen Receptor Function in White Adipocyte DevelopmentK01DK081446 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI HE, BIN · 2008 to 2010
$344k
NCI NIH HHS P30 CA125123NIAID NIH HHS R21 AI122418NIAID NIH HHS R33 AI122418NICHD NIH HHS R01 HD042311NIDDK NIH HHS K01 DK081446
6 · The paper itself

Abstract

GATA transcription factors are essential in mammalian cell lineage determination and have a critical role in cancer development. In cultured prostate cancer cells, GATA2 coordinates with androgen receptor (AR) to regulate gene transcription. In the murine prostate, among six GATA members, GATA2 and GATA3 are expressed. Immunofluorescence staining revealed that both GATA factors predominantly localize in the nuclei of luminal epithelial cells. The pioneer factor FoxA1 is exclusively detected in the luminal cells, whereas AR is detected in both luminal and basal cells. Using genetic engineering, we generated prostate-specific GATA2 and GATA3 knockout (KO) mice. Ablation of single GATA gene had marginal effect on prostate morphology and AR target gene expression, likely due to their genetic compensation. Double KO mice exhibited PIN III to IV lesions, but decreased prostate to body weight ratio, altered AR target gene expression, and expansion of p63-positive basal cells. However, deletion of GATA2 and GATA3 did not reduce the mRNA or protein levels of AR or FoxA1, indicating that GATA factors are not required for AR or FoxA1 expression in adult prostate. Surprisingly, GATA2 and GATA3 exhibit minimal expression in the ventral prostatic (VP) lobe. In contrast, FoxA1 and AR expression levels in VP are at least as high as those in anterior prostatic (AP) and dorsal-lateral prostatic (DLP) lobes. Together, our results indicate that GATA2 and GATA3 are essential for adult murine prostate function and in vivo AR signaling, and the lack of the GATA factor expression in the VP suggests a fundamental difference between VP and other prostatic lobes.

Indexed as

AnimalsGATA Transcription FactorsGenetic EngineeringHepatocyte Nuclear Factor 3-alphaHumansMaleMiceMice, KnockoutProstateReceptors, AndrogenFoxa1 protein, mouseGATA Transcription FactorsHepatocyte Nuclear Factor 3-alphaReceptors, Androgenandrogen receptorFoxA1GATA2GATA3prostate cancer

Identifiers

PMID27374105
PMCPMC5216986
OpenAlexW2470667884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.